Meta-analysis of RCTs finds SGLT-2 inhibitors improve weight loss in T2DM patients
Using sodium-glucose cotransporter 2(SGLT-2) inhibitors improves body composition in T2DM patients including body weight, body mass...
top of page
Browse by category
Search
ReShape awarded Grant to further develop Diabetes Bloc-Stim Neuromodulation device
ReShape Lifesciences has been awarded a US$300,000 Small Business Innovation Research (SBIR) grant for the development of ReShape’s...
Browse by tag
bottom of page